Interview

Meme Coin GME On Solana Skyrockets Following Keith Gill's Return To Social Media: Interview
'Equity Is More Than A Policy Statement': New Initiative Aims to Reshape New Jersey's Cannabis Industry
EXCLUSIVE: Ispire's CEO Michael Wang Predicts Vaping Will Soon Surpass Cannabis Flower Sales
'Equity Is More Than A Policy Statement': New Initiative Aims to Reshape New Jersey's Cannabis Industry
EXCLUSIVE: Ispire's CEO Michael Wang Predicts Vaping Will Soon Surpass Cannabis Flower Sales
Curaleaf International Is Beating Illicit Cannabis Prices In UK And Germany - What's Next For EU Expansion?
Beyond Europe And North America: Curaleaf's Strategist On Cannabis Markets In Australia, New Zealand, And Israel

Interview Recent News

EXCLUSIVE: Andrew Left Has 'Small' Short Position In GameStop As Roaring Kitty Nears YouTube Return — 'I'm Not Surprised By Today's Move Whatsoever'
Short seller Andrew Left doesn't believe the new GameStop trade was done entirely by Roaring Kitty and that something is fishy about the trade.
EXCLUSIVE: How NFL Veterans Calvin Johnson And Rob Sims Succeeded As Sports-Focused Cannabis Entrepreneurs
Discover how NFL legends Calvin Johnson Jr. and Rob Sims excel as cannabis industry entrepreneurs with their innovative wellness brand.
'AI Can Be A Hugely Democratizing Tool': Wendy Kopp Discusses Future Of Education
Kopp of Teach for All discusses leadership skills, empowering disadvantaged communities through education, and the role of AI in education.
EXCLUSIVE: Learn How This Cannabis Banking Innovator's 'Lead with Lending' Strategy Drives Financial Success
Safe Harbor Financial shares their strategy behind a 245% net income surge, innovative credit solutions and future trends in cannabis banking.
EXCLUSIVE: Green Check Verified Lands $100M In Financing Requests, Partners With Brinks, Coda Capital
Kevin Hart reveals Green Check Verified's success at Benzinga Cannabis Capital Conference, securing $100M+ in financing and partnership with Brinks.
EXCLUSIVE: 'Creating Secure AI for Everyone,' Says Co-CEO Of Brand Engagement Network
AI Unleashed: Exploring the Possibilities introduced BEN's AI advancements and HIPAA compliance, emphasizing security, privacy, and market growth.
Interview: Martha Stewart Says She Enjoys 'Baking' With Snoop Dogg As She Discusses Latest 420-Fashion Collab
“As I reflect on my recent collaboration with Snoop, I realize I learn so much from him every time we work together. He’s taught me about music and business and always gives me a fresh perspective.
Federal Cannabis Shift: 'The Industry Is Projected To Surpass $100 Billion By 2030,' Says Expert
Justice Department proposes reclassifying marijuana from Schedule I to III, acknowledging its medical benefits but not legalizing recreational use. Federal involvement may increase regulatory complexity for financial institutions.
EXCLUSIVE: Cybersecurity Critical For AI Growth — 'The Five Players Get Bigger... And Hopefully Better,' Says Stephanie Link (UPDATED)
Stephanie Link shares her investment strategy focused on India's economic growth, semiconductor industry's potential, and importance of cybersecurity at Benzinga's AI Unleashed event.
EXCLUSIVE: 'People Love THCV Before The Gym' Says Phylos Executive On Cannabis Genetics Advancements
On Benzinga's Cannabis Insider, Phylos' Whitney Conroy shared groundbreaking developments in the company's advancements in THCV research.
Cannabis Now Surpasses Alcohol: 'This Trend Will Continue for Decades,' Says Expert
Cannabis consumption has surpassed daily alcohol use for the first time in the US, with 17.7M daily users. Experts predict impact on market and call for diverse product offerings.
California's Famous Cannabis Goes To Europe: Rescheduling Drives Demand For De-Risked, Pest-Free, Low-Cost Plants
In an exclusive interview with Benzinga Cannabis, Kevin Brooks, CEO of Conception Nurseries, discussed his company's potential impact on the cannabis industry amid the anticipated federal rescheduling.
EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases
Coya Therapeutics is working On neurodegenerative disease treatment with its combination therapies targeting regulatory T cells. CEO Howard Berman discusses the potential of COYA 302 for ALS, FTD, Parkinson's, and Alzheimer's, emphasizing a transformative approach to immune balance restoration.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers